GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Total Long-Term Liabilities

Guobang Pharma (SHSE:605507) Total Long-Term Liabilities : ¥363 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Guobang Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Guobang Pharma's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥363 Mil.

Guobang Pharma Total Long-Term Liabilities Historical Data

The historical data trend for Guobang Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guobang Pharma Total Long-Term Liabilities Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial 261.96 13.87 26.20 474.83 170.59

Guobang Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 617.05 250.60 224.70 170.59 363.36

Guobang Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Guobang Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Guobang Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Guobang Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Total Long-Term Liabilities
Comparable Companies
SZSE:301263 SZSE:002317 SZSE:002020 SHSE:600572 SHSE:600211 SHSE:600267 SZSE:300026 SZSE:300119 SHSE:603567 SHSE:600129 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Website
http://www.gbgcn.com
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.

Guobang Pharma Headlines

No Headlines